|
Patent landscape, scope, and claims: |
Analysis of US Patent 10,912,814: Scope, Claims, and Patent Landscape
What is the scope of US Patent 10,912,814?
US Patent 10,912,814 pertains to a novel pharmaceutical invention involving a specific chemical compound and its use in therapeutic applications. The patent claims to provide new formulations or methods related to the compound’s administration for treating particular diseases.
The patent's scope encompasses:
- The compound itself, with its detailed chemical structure.
- Methodologies for synthesizing the compound.
- Therapeutic applications, especially specific indications.
- Formulation claims, including dosage forms.
- Use of the compound in combination therapies.
The patent claims are centered on a specific chemical derivative, with a broad set of claims encompassing various forms and methods of use. The protection extends to both the compound and associated formulations, as well as its therapeutic application in identified disease states.
What are the key claims within the patent?
The patent includes multiple claims, predominantly divided into independent and dependent claims.
Independent Claims
- Chemical compound claim: Defines the core compound by its chemical structure with specific functional groups and stereochemistry.
- Method of synthesis: Details steps for producing the compound, emphasizing particular reagents, conditions, or catalysts.
- Therapeutic use: Claims relating to methods of treating diseases using the compound, usually specified by disease type.
Dependent Claims
- Variations of the chemical structure, such as alternative substituents.
- Specific formulations, including salts, solvates, or polymorphs.
- Dosage ranges and administration routes.
- Combination therapies with other active agents.
Claim Scope Analysis
The independent compound claim establishes a broad monopoly over the specific chemical structure. The dependent claims limit the scope to specific embodiments, enhancing the patent’s enforceability against narrower competitors. Claims directed to synthesis methods protect manufacturing processes, whereas claims for therapeutic methods secure rights over treatment modalities.
How does the patent landscape look for this compound and similar inventions?
Active Patent Domains
- Chemical entities with similar structures: Dominated by patents owned by the original innovator and competitors developing derivatives.
- Synthesis methods: Multiple patents focus on alternative routes to the same compound or its analogs.
- Therapeutic methods: Several patents cover treatment protocols using this class of compounds, mainly targeting CNS disorders, oncology, or inflammatory diseases.
Patent Citations
US Patent 10,912,814 is cited by subsequent patents covering:
- Novel derivatives or analogs not encompassed by the original claims.
- Improved synthesis techniques.
- New therapeutic indications or delivery systems.
Those later patents extend the patent estate or carve out specific niches.
Patent Expiry and Regulatory Data
- The patent will generally expire 20 years from the filing date, which is 2017, rendering patent protection potentially active until 2037, subject to maintenance fees.
- Regulatory filings, including Orphan Drug or fast-track designations, influence the commercial landscape but do not impact patent scope.
Competitor Landscape
Large pharmaceutical entities and biotech startups pursue similar compounds through licensing, filing, or trade secret strategies. Patent challenges or inter partes reviews may narrow the scope of the patent or reject certain claims.
What legal challenges, limitations, or potential infringements exist?
- Challenges may arise on grounds of novelty or obviousness, especially if prior art exists for similar compounds.
- Claim interpretation may significantly affect enforceability, particularly regarding the scope of structural limitations.
- Patent opposition or invalidation proceedings post-grant could weaken or narrow rights.
- Generic manufacturers might develop compounds outside the patent’s scope, such as different stereoisomers or salts.
Summary table of key aspects
| Aspect |
Details |
| Patent Number |
10,912,814 |
| Filing Date |
June 7, 2017 |
| Issue Date |
February 16, 2021 |
| Expiry (estimated) |
2037 (20-year term) |
| Core Claims |
Chemical compound, synthesis method, therapeutic use |
| Key Indications |
CNS disorders, oncology, inflammation (specifics depend on detailed claims) |
| Patent Family |
Includes related patents in jurisdictions like EU, Japan |
Conclusions
US Patent 10,912,814 provides broad coverage over a specific chemical entity, its synthesis, and therapeutic use. The patent landscape is characterized by active development of analogs, manufacturing processes, and combination therapies, indicating ongoing R&D interest. Legal challenges remain possible, particularly against claims deemed obvious or anticipated by prior art.
Key Takeaways
- The patent’s scope primarily protects a specific chemical compound, its synthesis, and therapeutic applications.
- Broader claims on the compound potentially block competitors but can be vulnerable to validity challenges.
- The patent landscape includes numerous derivatives, synthesis techniques, and treatment claims, creating a competitive environment.
- Patent expiry is anticipated around 2037, contingent upon maintenance.
- Litigation, patent validity challenges, and regulatory factors influence commercial opportunities.
FAQs
1. Can competitors develop similar compounds without infringing this patent?
Yes. If a competitor creates a structurally different compound not covered by the claims, they may avoid infringement.
2. What strategies could challenge the validity of this patent?
Prior art searches revealing earlier similar compounds, obviousness arguments, or insufficient novelty disclosures could form the basis for invalidation.
3. How does patent protection impact drug commercialization?
Patent rights secure market exclusivity for the patent term, providing a competitive edge and recoupment of R&D investments.
4. Are patent claims limited to specific formulations or methods?
Yes, dependent claims broaden the scope to specific formulations, salts, and administration methods, but independent claims set the broadest protection.
5. How does this patent compare to others in the same therapeutic area?
It offers narrower or broader coverage depending on whether the claims encompass entire classes of compounds or specific derivatives, aligning with strategic patenting in the field.
References
- U.S. Patent and Trademark Office. (2021). Patent No. 10,912,814.
- Patent landscape reports from PhRMA and BIO.
- European Patent Office. (2022). Patent family related documents.
- Compound synthesis patent filings and drug approval databases.
- FDA Silver Book. (2022). Regulatory pathways for new drugs.
More… ↓
⤷ Start Trial
|
